Company Data

NeuBase Therapeutics Inc.

Ticker
NBSE
Current Price
$0.378
Market Cap
$1.4M
Price Target
Refer to Report
Volume
171.0K
52wk Range
$0.36 - $3.16
Advanced Market Data

Overview

NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington’s Disease, Myotonic Dystrophy and Familial Parkinson’s Disease among others.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy